Where does Abbott Molecular Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Abbott Molecular Inc. ranks #3,796 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Abbott Molecular Inc. hold?

Abbott Molecular Inc. holds 95 US utility patents granted between 2015 and 2025, spanning 19 technology areas.

What is Abbott Molecular Inc.'s Innovation Score?

Abbott Molecular Inc. has an Innovation Score of 41.4 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Abbott Molecular Inc.'s patent grant rate increasing or decreasing?

Abbott Molecular Inc.'s recent grant velocity is -38% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Abbott Molecular Inc.'s patents?

Abbott Molecular Inc.'s patents average 13.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Abbott Molecular Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Abbott Molecular Inc.

Q: What technology areas does Abbott Molecular Inc. focus on?

Abbott Molecular Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 80 patents, ranking #52 of 2,502 assignees active in that subclass. Grants appear in 19 CPC subclasses total.

USPTO PatentsView assignee record - 95 granted patents across 19 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abbott ranks #3,796 of 49,997 tracked US assignees by granted-patent volume, with 95 patents across 19 technology areas.

#3,796
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.4/100): 13.7
avg claims per patent: -38%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3796 · US Corporation #3,796 · 95 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 95 grants
TOP-DECILE #3,796/49,997
PHOTO-FINISH American Airlines
CPC-FOCUS C12Q · 19 areas
INNOV-PAR 41.4/100
CLAIMS-RICH 13.7 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -38% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: American Airlines, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Abbott’s 41.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.8 pts (38%) Velocity 2.0 pts (5%) Breadth 15.4 pts (37%) Claim depth 8.2 pts (20%)

Qualcomm Incorporated · highest

85
zSpace · near

41
Abbott Molecular · this assignee

41
Magna Powertrain of… · near

41
Secure-ic SAS · near

41
Hitachi Construction… · near

41
3D Lighting… · lowest

7

What this shows Abbott's Innovation Score is 41.4/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Abbott?

Each dot is one of Abbott’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abbott’s own 13.7 claims/patent is at or below the 18.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Abbott vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Abbott's grants concentrate

Abbott Molecular Inc. is a focused PatentsView assignee: 19 CPC subclasses with 84.2% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2018 (18 grants) versus a trough of 1 in 2023. By volume, Abbott sits between Wi-LAN Inc. and Cortica Ltd..

Abbott's three-year grant acceleration

From 2019–2021 to 2022–2024, Abbott Molecular Inc. moved from 36 to 11 grants (0.31x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Wi-lan

96
Wix com

96
Zimmer Biomet Spi…

96
American Airlines

95
Beijing Roborock…

95
Cabot Microelectr…

95
Comcast Cable Com…

95
Cortica

95
Abbott Molecular ◀

95

What this shows Abbott holds 95 patents at rank #3,797, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abbott

By rank, the assignees closest to #3,797 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Abbott's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Abbott, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Abbott ranks #52 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Magna Powertrain of America, Inc. 41 Secure-ic SAS 41 zSpace, Inc. 41 Hitachi Construction Machinery Tierra Co., Ltd. 41

Similar claim depth

Nearest assignees by average claims per patent (13.7 here).

ALi Corporation 13.7 avg Dupont Electronics, Inc. 13.7 avg Duksan Neolux Co., Ltd 13.7 avg Alstom Technology Ltd 13.7 avg

Abbott's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Abbott Molecular Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	9.5%
2016	11	11.6%
2017	9	9.5%
2018	18	18.9%
2019	11	11.6%
2020	14	14.7%
2021	11	11.6%
2022	6	6.3%
2023	1	1.1%
2024	4	4.2%
2025partial year	1	1.1%

Which technologies does Abbott Molecular Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 80

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 27

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 23

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 15

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 13

C01G - Compounds Containing Metals NOT Covered BY Subclasses C01d OR C01f 4

C01P - Indexing Scheme Relating TO Structural AND Physical Aspects OF Solid Inorganic Compounds 4

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 2

G02B - Optical Elements, Systems OR Apparatus 2

C07D - Heterocyclic Compounds 1

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Abbott Molecular Inc.'s patent record in context - here's where to go next.

Abbott Molecular Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 84.2% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #3,796 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Abbott Molecular Inc. against Wi-LAN Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.